Nebula Research & Development LLC Purchases New Shares in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Nebula Research & Development LLC bought a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 1,549 shares of the medical equipment provider's stock, valued at approximately $809,000.

A number of other large investors have also recently made changes to their positions in the company. Atala Financial Inc acquired a new position in Intuitive Surgical in the fourth quarter valued at approximately $25,000. Berbice Capital Management LLC acquired a new stake in shares of Intuitive Surgical in the fourth quarter valued at approximately $26,000. BankPlus Trust Department acquired a new stake in shares of Intuitive Surgical in the fourth quarter valued at approximately $28,000. Hurley Capital LLC acquired a new stake in shares of Intuitive Surgical in the fourth quarter valued at approximately $28,000. Finally, Summit Securities Group LLC acquired a new stake in shares of Intuitive Surgical in the fourth quarter valued at approximately $30,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

ISRG has been the subject of several research analyst reports. Robert W. Baird decreased their price objective on Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating for the company in a report on Wednesday, April 23rd. UBS Group increased their price objective on Intuitive Surgical from $500.00 to $560.00 and gave the company a "neutral" rating in a report on Monday, January 27th. Erste Group Bank downgraded Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a report on Monday, March 17th. Leerink Partners increased their price objective on Intuitive Surgical from $490.00 to $548.00 in a report on Monday, January 27th. Finally, JPMorgan Chase & Co. raised their price target on Intuitive Surgical from $575.00 to $675.00 and gave the company an "overweight" rating in a research report on Friday, January 24th. Five equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $598.95.

Insider Transactions at Intuitive Surgical

In other news, EVP Robert Desantis sold 11,545 shares of the stock in a transaction on Thursday, March 13th. The shares were sold at an average price of $499.22, for a total value of $5,763,494.90. Following the completion of the sale, the executive vice president now owns 5,224 shares of the company's stock, valued at $2,607,925.28. This represents a 68.85 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Brian Edward Miller sold 8,900 shares of the stock in a transaction on Tuesday, March 11th. The stock was sold at an average price of $485.07, for a total transaction of $4,317,123.00. Following the completion of the sale, the executive vice president now directly owns 5,758 shares of the company's stock, valued at $2,793,033.06. The trade was a 60.72 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 30,913 shares of company stock valued at $15,981,143 over the last 90 days. Corporate insiders own 0.70% of the company's stock.

Intuitive Surgical Price Performance

NASDAQ:ISRG traded up $0.91 during trading hours on Wednesday, reaching $515.80. 1,650,105 shares of the company were exchanged, compared to its average volume of 1,619,216. The firm has a market cap of $184.87 billion, a price-to-earnings ratio of 80.47, a PEG ratio of 5.85 and a beta of 1.55. Intuitive Surgical, Inc. has a 52-week low of $367.39 and a 52-week high of $616.00. The stock has a 50 day simple moving average of $508.20 and a 200 day simple moving average of $533.13.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, topping analysts' consensus estimates of $1.71 by $0.10. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. The company had revenue of $2.25 billion for the quarter, compared to the consensus estimate of $2.19 billion. During the same quarter last year, the firm posted $1.50 earnings per share. On average, analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.